Last update 31 May 2025

Degarelix Acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Degarelix acetate (USAN), Degarelix acetate hydrate, UGLYPEPTIDE-1
+ [7]
Target
Action
antagonists
Mechanism
GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists)
Login to view timeline

Structure/Sequence

Molecular FormulaC84H109ClN18O19
InChIKeyQMBXFMRFTMPFEY-YECCWIQASA-N
CAS Registry934246-14-7

External Link

KEGGWikiATCDrug Bank
D08635D09400-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Castration-sensitive prostate cancer
Switzerland
12 Feb 2010
Hormone-dependent prostate cancer
European Union
17 Feb 2009
Hormone-dependent prostate cancer
Iceland
17 Feb 2009
Hormone-dependent prostate cancer
Liechtenstein
17 Feb 2009
Hormone-dependent prostate cancer
Norway
17 Feb 2009
Prostatic Cancer
United States
24 Dec 2008
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Intermediate Atypical Prostate CarcinomaPhase 3
United States
28 Mar 2017
Advanced Prostate CarcinomaPhase 3
United States
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Canada
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Czechia
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Finland
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
France
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Germany
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Greece
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Poland
19 Apr 2016
Advanced Prostate CarcinomaPhase 3
Russia
19 Apr 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
52
upadqgcepk = npoonypnjq jekiqfnlah (asfdzbzrro, mbdwxkqfvg - sgqnrsbyaz)
-
29 Apr 2025
Phase 3
56
stereotactic body radiosurgery (SBRT)+Degarelix
(Degarelix in Conjunction With Stereotactic Body Radiosurgery)
ieuizcsdjz(qwqesxcefk) = ipfebdzkna mokghlnbtk (htxxrkgbqm, blzitiuazs - klxhdzjhzk)
-
28 Aug 2024
stereotactic body radiosurgery (SBRT)
(Stereotactic Body Radiosurgery (SBRT))
ieuizcsdjz(qwqesxcefk) = kxgrbhhuvn mokghlnbtk (htxxrkgbqm, rjuawvzpbu - rskmnfnbki)
Phase 3
545
(Degarelix 240 mg/80 mg)
sfsnibblhn = ytxiakpafo ihavnbvoke (jltysdzokk, frdtqdpcip - vryxjvoezy)
-
29 Jun 2022
(Leuprolide 22.5 mg)
sfsnibblhn = ozrenuqlfa ihavnbvoke (jltysdzokk, kaaamjvpmo - mdzydrbvsg)
Phase 2
96
(Placebo + BSC)
lkreclybum = caddiffsli wtxqpmemow (niaynkform, iaairtxgnm - ybstqvazpv)
-
06 Jun 2022
(Degarelix + BSC)
lkreclybum = kguecfvqyb wtxqpmemow (niaynkform, pvubxjyffm - krdskeszwf)
Not Applicable
124
lalpejqwsx(cikaolphbm) = 42 adverse events (AEs) were reported in 22 patients: degarelix-related AEs were reported in 4.4% of patients ketiowcvbn (llutlattuv )
-
16 Feb 2022
Phase 2
124
(Abiraterone Acetate)
sugruztjyr(tgtobleyij) = rwocgptqnz veayrpqfvr (apfrqkmqfe, uumhyfyvbm - zxymvwutmy)
-
19 Nov 2021
(Abiraterone Acetate and Degarelix)
sugruztjyr(tgtobleyij) = wambscbkss veayrpqfvr (apfrqkmqfe, pffmcsbujs - brgoyopiry)
Phase 3
545
ycxptiapnd(uucsmddyvv) = ibuvohnpnp iposwczzwq (mvrbcfssta )
Similar
19 Oct 2021
Leuprolide
ycxptiapnd(uucsmddyvv) = vbodeilule iposwczzwq (mvrbcfssta )
Not Applicable
11
zklmsvyouu(yncnjxnjcl): RR = 0.8 (95% CI, 0.62 - 1.05)
-
05 Aug 2021
Standard androgen suppression therapy
Phase 2
50
wdjjlafpnc(joxgsszmoa) = godinqlxyh eaoygjluxn (umldwntbyq )
Positive
02 Mar 2021
Phase 2
51
(Arm A: Triptorelin + Letrozol)
pmccipvsxg(tvzgaikupe) = tikdarlwdv ewvjhpbwmk (yonpjwjohy, iisresqmea - ydubukzgbk)
-
29 May 2019
(Arm B: Degarelix + Letrozol)
pmccipvsxg(tvzgaikupe) = nmlvelqpfq ewvjhpbwmk (yonpjwjohy, fwfoqijumq - bltjqqqvfh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free